A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease

NCT03888716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitochondrial Diseases
Mitochondrial Respiratory Chain Deficiencies
MELAS Syndrome
Mitochondrial Myopathies

Interventions

DRUG: KL1333
DRUG: Placebo Oral Tablet

Sponsor

Abliva AB